JUNE 11, 2021

Does SARS-CoV-2 Have a Buddy? Vaccine Safety in Special Populations and Other News

By Marie Rosenthal, MS

Several studies have shown that special populations, such as cancer patients and those with irritable bowel disease, do quite well after receiving a COVID-19 vaccine. Dialysis patients who are at a higher risk for death from COVID-19, also fared well after vaccination. The Centers for Medicare & Medicaid Services is trying to make it easier for homebound people to get a COVID-19 vaccine. Finally, has SARS-CoV-2 found a microbial buddy?

Dialysis Patients Face Higher Risk